| | | | | |
BDSX Biodesix, Inc. Common Stock | $21,6800 | -2,12 % | $227,72M | $97,96K | |
IRAB Iris Acquisition Corp II | $10,0700 | +1,21 % | $227,67M | $34,86K | |
REFI Chicago Atlantic Real Estate Finance, Inc. Common Stock | $10,8300 | +1,31 % | $227,63M | $80,30K | |
SMTI Sanara MedTech Inc. Common Stock | $23,7750 | -0,44 % | $227,63M | $67,50K | |
SABA Saba Capital Income & Opportunities Fund II | $8,1800 | -0,24 % | $227,54M | $92,49K | |
CRAC Crown Reserve Acquisition Corp. I Class A Ordinary Shares | $10,1050 | -0,15 % | $226,14M | $19,64K | |
NPV Nuveen Virginia Quality Municipal Income Fund | $11,4100 | -0,18 % | $225,55M | $37,66K | |
OPBK OP Bancorp Common Stock | $14,8600 | +1,30 % | $225,49M | $16,52K | |
PNNT Pennant Investment Corp | $3,4400 | +1,18 % | $225,27M | $498,64K | |
AOMR Angel Oak Mortgage REIT, Inc. | $9,0100 | +0,78 % | $225,22M | $73,88K | |
| $2,4200 | -5,47 % | $224,51M | $550,51K | |
| $6,7500 | +3,69 % | $224,42M | $369,74K | |
CHRS Coherus Oncology, Inc. Common Stock | $1,5500 | -4,91 % | $223,66M | $930,77K | |
KROS Keros Therapeutics, Inc. Common Stock | $11,8100 | -1,83 % | $222,85M | $259,09K | |
QTTB Q32 Bio Inc. Common Stock | $15,9500 | +26,69 % | $221,95M | $3,50M | |
